It shouldn't really be a surprise that artificial intelligence (AI) gets a special mention in the long-term plan for the NHS, published in March. AI is seen as important for the future of the NHS because it can make healthcare more effective and efficient, leaving staff free to focus on, as the plan puts it, the'complexity of human interactions that technology will never master'. With a growing population, limited resources yet more and more treatments available, the use of intelligent technology will be key to ensuring our healthcare services can keep pace. At Grow MedTech, we see AI as one of the most important digital technologies that will combine with traditional medtech to create the products and technologies of the future. And Yorkshire is a hotbed for the technology, with all of our partner universities offering expertise in the field.
San Jose, Sept. 26, 2017 – MedTech Innovator announced today Day Zero Diagnostics as the winner of its 2017 global competition. The Boston-based company was selected in a real-time vote by an audience of nearly 1,500 at The MedTech Conference powered by AdvaMed. This year's winner, Day Zero Diagnostics is combining genome sequencing and machine learning to combat antimicrobial resistant infections, enabling physicians to switch from broad-spectrum antibiotic therapy to a targeted antibiotic in hours rather than days. CEO Jong Lee participated in MedTech Innovator's expansive, customized accelerator program, which included in-depth mentorship from senior leaders in the medtech industry, exclusive networking opportunities, virtual and in-person workshops, and pitching with investors, manufacturers, providers, and customers. "It was a record-breaking year for MedTech Innovator, with no shortage of amazing talent and transformative technologies, and we're thrilled to see Day Zero Diagnostics selected as the 2017 winner," MedTech Innovator CEO Paul Grand said.
Artificial intelligence (AI) is rapidly spreading throughout the realm of medtech as companies from every corner of the market look to adapt to the latest in innovation. Whether you're an industry giant, or a shiny new startup, advancements in AI technologies are forcing companies to embrace and adapt to new developments--all while altering the medtech landscape in the process. How are companies beginning to tap their potential, and when will we begin to actually see the impact they can have on the world of healthcare? These are some of the questions that Gioel Molinari will be addressing at next month's MD&M East 2018 conference in New York, where he'll be part of a panel discussion on the topic of "How Artificial Intelligence is Moving the Needle in Medtech." Molinari is the current president of Butterfly Network Inc., a cutting-edge technology company that focuses on semiconductor technologies, cloud platforms, and artificial intelligence and deep learning technologies that can shape next-gen devices.
Recently I chatted with Candace Roulo, managing editor of Advanced Manufacturing Now, about some of the most important trends in medtech and the technologies that are taking the industry to the next level. Click below to listen to the podcast, or read on for select highlights of the conversation – what I consider to be five trends medtech professionals should be talking about. Advanced Manufacturing Now: You mentioned connectivity. With the healthcare sector embracing the interconnectivity of the Internet of Things for more proactive patient management, what are the opportunities and challenges associated with using sensors in medical devices? And if you could, give us a couple examples of those medical devices.
Artificial intelligence raises exciting possibilities for healthcare, but are companies promising more than they can deliver? But artificial intelligence's potential also comes with an incredible level of hype. "AI has the most transformative potential of anything I've seen in my life, and I graduated medical school 40 years ago. It's the biggest thing I've ever seen by far," prominent cardiologist and author Dr. Eric Topol told Medical Design & Outsourcing. "But it's more in promise than it is in reality."